Objective: To show the impact of learning curve and patient selection on complication rate and biochemical recurrence-free survival of a UK radical prostatectomy series for localised prostate cancer and to model the influence of common preoperative variables on biochemical recurrence after controlling for learning curve. Patients and Methods: From 1989 to 1999, 280 of 350 patients who underwent anatomical radical retropubic prostatectomy (RRP) at our institution had complete records and follow-up of at least 1 y. After exclusions of preoperative staging, factors reflecting the learning curve, early complications and prostate-specific antigen (PSA) outcome were recorded on 217 patients. Procedures before 1995 were compared with procedures after 1995. Results: Comparison of the two groups showed a significant decrease in operating time (mean 152 vs 130 min), blood loss (mean 1500 vs 1000 ml), transfusion rate (83 vs 42%) and hospital stay (mean 7 vs 6 days). Median preoperative PSA changed significantly from 13.2 to 11.5 ng/ml. Only 17% were diagnosed by rectal examination compared to 27% in the early years. The number of clinical T1 tumours increased from 33 to 47%. This did lead to an increase of organ-confined tumours on pathological staging by 25%. Biochemical recurrence-free survival improved significantly after 1995. After controlling for the learning curve PSA and clinical stage were significant predictors of PSA recurrence. Conclusion: Time trends of case selection, stage migration and a steep learning curve are shown over a 10-y period. Factors associated with the learning curve as well as case selection have a significant impact on outcome. There may be other as yet not specified factors over time, which have a significant impact on PSA recurrence-free survival. Patients with a PSA of 20 ng/ml and above have a poor outcome and do not appear to be suitable candidates for RRP.
Introduction
Worldwide an increasing number of radical prostatectomies are performed with the intention to cure clinically localised prostate cancer and yet 16-42% [1] [2] [3] [4] have positive resection margins and up to 56% [5] [6] [7] do show disease recurrence. There has been a sharp increase of the number of radical prostatectomies in the US mirrored with some delay in the UK. 8 In general, most urologists believe that radical prostatectomy presents the highest chance of cure for truly organ-confined adenocarcinoma of the prostate. Accurate preoperative staging and prediction of disease relapse is urgently needed to select the right patients for curative treatment. Prostate-specific antigen (PSA), biopsy Gleason grade and clinical stage have often been identified as prognostic factors for biochemical recurrence. Nomograms incorporating these parameters are now available and used to improve patients selection. Perioperative mortality of radical retropubic prostatectomy (RRP) is generally low; however, treatment-related morbidity could have long-lasting negative effects on the quality of life after surgery. When this procedure was first adopted in the UK, only few operations were carried out in the hands of many surgeons. 8 This is partly explained by the inherent lack of specialists, superspecialisation and centralisation of urological services in the UK. It is generally accepted by the medical profession that the skill to perform a major surgical procedure has to be acquired under supervision but a certain learning curve is unavoidable, though this fact is often disputed by the lay press, patients lobby groups and government institutions. It is conceivable that factors representing the learning curve may well have an impact on outcome after radical prostatectomy just as patient selection has. We set out to investigate the impact of learning curve and patient selection on complication rate and biochemical recurrence free survival of a UK radical prostatectomy series for localised prostate cancer. In addition, we modelled the influence of common preoperative variables on biochemical recurrence after controlling for learning curve. Our results might have a bearing on interpretation of results reported by American centres that have longer follow-up and much more experience, although these centres have a much tighter patient selection (majority stage T1 and PSAo10) which influence complication rate and outcome.
Patients and methods

Clinical data
Patients were selected on the basis of full clinical follow-up of at least 1 y and complete clinical notes. In total, 280 of 350 patients fulfilled these criteria and all had undergone anatomical RRP and pelvic lymphadenectomy at Southmead Hospital or nearby Weston General Hospital between 1989 and 1999. After excluding patients who had received neoadjuvant hormonal therapy, adjuvant radiotherapy or early hormonal ablation and had o12 months follow-up, 217 patients were available for analysis. Biochemical recurrence was defined as sustained elevations of serum PSA 40.2 ng/ml on at least two occasions. The method of pathological assessment did only change marginally although a number of specimens were contracted out for processing and reporting. Those specimens were whole mounted. For that reason, all the prostatectomy specimens were reviewed by a histopathologist specialised in urological pathology and Gleason score, pathological stage and margin status were uniformly assigned. The Gleason scores were grouped into three groups (2-4, 5-6, Z7). Staging followed the 1997 TNM classification. Bladder neck stenosis was defined as any patient who required a bladder neck dilatation or incision at any time postoperatively. Incontinence was defined here for comparative purpose as the use of no pad per day (dry or minimal incontinence), one to three pads per day and more than three pads per day or artificial urinary sphincter required.
Statistical analysis
All patients undergoing pelvic lymphadenectomy and RRP including patients with positive lymph nodes were considered on an intention to treat basis. The outcome of interest was biochemical recurrence. Cox proportional hazards regression was used to identify factors associated with biochemical recurrence. The models were built in stages using the modelling scheme suggested by Collett.
9 Survival curves for the factors found to be associated with biochemical recurrence were produced using the Kaplan-Meier method. Factors such as blood loss, length of operation, blood transfusion and length of postoperative stay were not considered to be of direct interest but thought to influence biochemical recurrence and were controlled for in the analysis. The proportional hazards assumption was assessed using the method described by Grambsch and Therneau 10 and implemented in the statistical package Stata (Stata Statistical Software version 6, Stata Corporation, College Station, TX, USA).
Continuity corrected w 2 test and Wilcoxon test were used to compare factors reflecting patient selection and learning curve.
Results
Patient ages ranged from 47 to 76 y with a median age of 63 y (lower quartile ¼ 60 y, upper quartile ¼ 67 y). Median follow-up was 60 months. Median PSA for all patients was 13.5 ng/ml and biochemical recurrence-free survival estimates for all patients at 1, 5 and 10 y were 95% (95% CI: 90-98), 72% (95% CI: 62-81) and 40% (95% CI: 18-61), respectively. A continuous increase in the number of RRPs to 1998 was observed (Figure 1 ). Numbers dropped slightly thereafter.
Comparison of factors reflecting a change in patient selection for procedures before and after 1995
Significantly fewer patients were diagnosed by direct rectal examination and the median preoperative PSA dropped significantly after 1995 (Table 1) . Clinical T1 tumours were diagnosed in 47% for procedures after 1995 (Table 1) . This translated into a significant increase of pathologically organ-confined disease and a reduction of positive surgical margin for procedures performed after 1995 (Table 1 ). The comparison of biochemical recurrence-free survival for procedures before and after 
Comparison of factors reflecting the learning curve for procedures before and after 1995
Operating time, blood loss, transfusion rate and hospital stay could all be shown to improve significantly (Table 2) .
Bladder neck stenosis decreased from 18 to 7% (P ¼ 0.01) and serious incontinence after 1-y of follow-up (the use of more then three pads per day or requirement of an artificial urinary sphincter) decreased from 8 to 4% (not significant). In all, 86% of patients were completely dry or had minor incontinence (no pads required) for procedures carried out after 1995 vs 83% before 1995 (not significant).
Cox proportional hazards regression for preoperative factors
Potential preoperative factors considered for analysis were age, PSA (0-10, 11-20, 420 ng/ml), clinical stage (T1, T2), biopsy Gleason score (2-4, 5 and 6, 7-10) and mode of presentation (symptoms suggestive of bladder outflow obstruction, digital rectal examination (DRE), transurethral resection of prostate (TURP), screening, haemospermia and haematuria). Factors believed to reflect the learning curve were controlled for. Preoperative PSA and clinical stage were associated with survival. Both factors were inter-related. For survival estimates and Kaplan-Meier curves see Figure 3 and Table 3 .
To investigate whether this multivariate model accounted for the large improvement in biochemical free survival after 1995 we introduced a dummy variable indicating whether the operation was pre-or post-1995. The multivariate analysis was repeated, controlling for factors believed to reflect the learning curve. This dummy variable was highly significant followed by PSA. This would suggest that there may be other prognostic factors beyond PSA and the learning curve factors that differed between the early and late operations which, if identified, could significantly improve the model's ability to predict biochemical recurrence.
Discussion
The focus of this paper was to investigate factors presumed to be associated with the learning curve of a surgeon and whether this learning curve has an impact on intermediate oncological outcome after radical prostatectomy in England in the PSA era. However, case selection for RRP has changed over the last 10 y 11,12 and it Learning curve and stage migration of RRP series MH Winkler and DA Gillatt was necessary to investigate these time trends to allow an unbiased view at the impact of a learning curve. Of the factors reflecting case selection only preoperative PSA showed a significant trend to lower PSAs; clinical stage showed an almost significant trend towards nonpalpable disease (Table 1) . Biopsy Gleason grade did not change significantly (w 2 2 ¼ 0.91). As a result a significant pathological stage migration was documented in this single surgeon series over a 10-y period (Table 1) . This observed stage migration was reflected in a significantly improved PSA recurrence-free survival (Figure 2) . Stage migration towards lower clinical and pathological stage has been demonstrated in other countries 11, 12 and likewise this has led to an improvement in recurrence-free survival rates. [12] [13] [14] It is encouraging to see that urologists in England have largely moved away from selecting patients with a preoperative PSA of 410 ng/ml for RRP with their associated higher rates of nonorgan-confined disease. 15 The median PSA in 1999 was 9.2 ng/ml (Table 1) .
Significantly, more patients were diagnosed and referred on the basis of a raised PSA and less due to an abnormal DRE (Table 1 ). It appears that the advent of PSA testing has helped to improve patient selection. Not only did this translate in a more favourable rate of pathologically organ-confined disease but also in a reduction of positive surgical margins (Table 1) . Despite an improvement of 14%, a positive surgical margin rate of 34% (and 32% in 1999) is still higher than in most other RRP series. [16] [17] [18] Perhaps English urologists still operate on larger volume cancers because screening healthy asymptomatic men (and finding asymptomatic, low-volume cancers) is currently not recommended by the Department of Health. The fact that more than 60% of patients after 1995 were diagnosed on the basis of lower urinary tract symptoms and/or a PSA test is encouraging and may reflect the increasing penetrance of opportunistic PSA screening. 19 A steep learning curve for this radical operation was demonstrated. All four factors (operating time, blood loss, transfusion rate and hospital stay) improved significantly over the time periods examined ( Table 2) . As expected, there was also a significant improvement in procedure-specific long-term complications incontinence and bladder neck stenosis. Given the fact that surgeon volume does have an impact on outcome and is inversely related to in-hospital complications and length of stay in men undergoing RRP, [20] [21] [22] the results of this study suggest that, perhaps, this procedure should rest in the hands of regional specialist centres.
Traditionally, urologists in England have been slow to take up this procedure to cure prostate cancer because there was a distinct lack of reliable data to support any specific recommendation for the treatment of early prostate cancer. The same is of course true for any other treatment modality for organ-confined prostate cancer. Numbers of operations performed were small prior to 1993 (o20 procedures/y) but began to increase from 1994 and reached a peak in 1998. Recently, Oliver et al 8 demonstrated a nearly 20-fold increase of the number of RRPs performed annually between 1991 and 1999 in England. They stated that these developments occurred in the absence of robust information about the effectiveness of RRP. There is now some evidence that radical prostatectomy can reduce death from prostate cancer. 23 PSA and clinical stage are the preoperative variables found to be associated with biochemical recurrence-free survival after controlling for factors reflecting the learning curve. In our series, biopsy Gleason grade was only significant on univariate analysis but dropped out on multivariate analysis (60% were Gleason 5 and 6) and data had to be stratified into three groups, which meant a loss of its information content. Patients with a PSA of 10 ng/ml or less and impalpable disease have an excellent 5-y biochemical recurrence-free survival of 91% mirroring the best published results. [16] [17] [18] In concordance with the literature, patients with a PSA of 420 should not undergo radical surgery (estimated 5 y biochemical recurrence-free survival 20% (95% CI: 6-41). 15, 16 Equally, patients with a PSA of 11-20 and clinical stage T2 disease have only a minor benefit from radical surgery (estimated 5-y biochemical recurrencefree survival 54% (95% CI: 37-69)).
As shown here, a survival analysis can be misleading when not taking into account factors that change during the long period of perfecting surgical skills. These factors should be controlled for. Despite controlling for the learning curve, we were unable to explain the large improvement in biochemical free survival after 1995. In an attempt to look for other factors related to outcome, we introduced a dummy variable indicating the date of operation into the model. This variable was by far the most powerful predictor of outcome, followed by PSA. This would mean that other factors, which have changed over time but have not been accounted for here, such as minor changes in surgical technique or, perhaps, changes in diet and secondary care or simply operating on smaller tumours with the phasing in of PSA testing, may have a very strong impact on survival. Minor adjustments in surgical technique are common during the learning curve and have also featured in this series. Changes were made to the dissection of the apex, the management of the dorsal venous complex, urethral stump preservation and bladder neck preservation with mucosal eversion. It is conceivable that these modifications have an impact on biochemical recurrence-free survival.
It is almost impossible to disentangle the competing impact of learning curve and case selection on outcome. From this analysis, we can assume that other factors beyond the usual preoperative predictors and factors associated with the learning curve may have a profound impact on outcome.
